Navigation Links
Genetic variant increases triglyceride levels in Asian-Americans
Date:7/17/2008

A genetic variant found almost exclusively in individuals of Asian descent increases the risk of elevated triglycerides over four-fold, reports a comprehensive study in the August Journal of Lipid Research. In fact, all 11 subjects who carried both copies of this rare variant for apolipoprotein A-V had extremely high and dangerous triglyceride levels in their blood.

Apolipoprotein A-V is a recently discovered lipid-binding protein that likely plays an important role in metabolizing triglycerides. Some population studies with groups in China and Taiwan indicate that a polymorphism in the APOA5 gene (553 G>T shift) is associated with elevated plasma TG levels, which like cholesterol, increase the risk of heart disease.

To get a broader view of this potentially important gene polymorphism, Clive Pullinger and colleagues examined the frequency and impact of this variant in a population of Chinese-Americans, as well as four other Asian-American populations (Japanese, Korean, Southeast Asian, and Pacific Islander).

The researchers examined 541 individuals and found that 15.1% of Chinese-Americans with high plasma TG (>150 mg/dl) carried at least one copy of the 553T variant, compared with only 3.7% of those with normal TG levels; in non-Chinese Asians these values were 13.7% and 5.4%. When calculated, the 553T variant corresponds to a 4.4 and 2.5 times greater risk of elevated TG in Chinese-Americans and other Asians, respectively.

The frequency became even more prevalent at higher levels; 60% of individuals with TG of >500 mg/dl carried the variant, and at 1000 mg/dl the frequency rose to 80%. And the 11 subjects who had the variant in both copies of their APOA5 gene had an average TG concentration of over 2000 mg/dl, which can pose serious health risks.

This specific genetic change seems restricted to Asians, as the researchers studied 779 non-Asian subjects and found only 3 incidences of the 553T variant (2 Caucasian and 1 Hispanic).


'/>"/>

Contact: Nick Zagorski
nzagorski@asbmb.org
301-634-7366
American Society for Biochemistry and Molecular Biology
Source:Eurekalert

Related biology news :

1. Genetic cause of innate resistance to HIV/AIDS
2. Statin does not appear helpful for children with learning disabilities caused by genetic disorder
3. The epigenetics of increasing weight through the generations
4. Sociological research shows combined impact of genetics, social factors on delinquency
5. Zooming in on genetic shuffling
6. Genetic Engineering & Biotechnology News reports on novel hit-to-lead drug discovery
7. HapMap browsing and DDDP methods for genetic analysis featured in CSH Protocols
8. Political participation is partially rooted in genetic inheritance
9. International team identifies 21 new genetic risk factors for Crohns disease
10. Why do people vote? Genetic variation in political participation
11. Automated microfluidic device reduces time to screen small organisms for genetic studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)...  Trovagene, Inc. (NASDAQ: TROV ), a ... that it has signed agreements with seven strategic partners ... Middle East for commercialization of the ... wave of international distribution agreements for Trovagene,s CLIA based ... The initial partners will introduce Trovagene,s liquid biopsy ...
(Date:1/12/2017)... PUNE, India , January 12, 2017 A new report ... 2022," projects that the global biometric technology market is expected to generate revenue of ... Continue Reading ... Allied ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) ...
(Date:1/11/2017)... , Jan. 11, 2017  Michael Johnson, co-founder of Visikol ... Capital Group, Inc., has been named to the elite "Forbes 30 ...  was one of 600 people in 20 fields nationwide to be ... of the 15,000 applicants were selected. ... He is currently a PhD candidate at Rutgers ...
Breaking Biology News(10 mins):
(Date:1/23/2017)... ... 23, 2017 , ... AxioMed will be presenting its viscoelastic ... in Montego Bay, Jamaica from January 26-28th. “We’re excited to be presenting the ... experience the simplicity of the surgical technique,” said Jake Lubinski, President of AxioMed. ...
(Date:1/21/2017)... , ... January 21, 2017 , ... ... endeavors to bring to market a pioneering medical device for the treatment of ... an engagement contract with Emergo, a global regulatory consultancy that helps companies like ...
(Date:1/21/2017)... , Jan. 21, 2017   Boston Biomedical ... compounds designed to target cancer stemness pathways, today presented ... compound, napabucasin, at the 2017 American Society of Clinical ... Francisco . In a Phase ... agent designed to inhibit cancer stemness pathways by targeting ...
(Date:1/20/2017)... -- http://www.Financialbuzz.com - According to ... of death worldwide. There were 8.2 million cancer related ... deaths increased gradually over time, the death rates have ... cancers continues to drive demand of biological therapies for ... Insights, Inc. cancer biological therapy market size was USD 61.3 ...
Breaking Biology Technology: